AVP-21D9
- Generic Name
- AVP-21D9
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 6RUU8A4K0R
- Background
AVP-21D9 is a fully human anthrax monoclonal antibody that is being investigated as an anthrax antitoxin.
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Emergent BioSolutions
- Target Recruit Count
- 50
- Registration Number
- NCT01202695
- Locations
- 🇺🇸
ICON Development Solutions, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath